DISCOVERY OF A NOVEL PHENYLAMINE-PURINE CHEMOTYPE AS A POTENTIAL EGFR INHIBITOR USING AN INTEGRATED AI-DRIVEN DRUG DESIGN PIPELINE
Al-Azhar Journal of Pharmaceutical Sciences · 14.05.2026 · 143-157
DOI: 10.21608/ajps.2026.504589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Azhar Journal of Pharmaceutical Sciences, online erschienen am 14.05.2026. Verfasst von Hany E. A. Ahmed und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ahmed, H. E. A., & Ashraf, A. (2026). DISCOVERY OF A NOVEL PHENYLAMINE-PURINE CHEMOTYPE AS A POTENTIAL EGFR INHIBITOR USING AN INTEGRATED AI-DRIVEN DRUG DESIGN PIPELINE. Al-Azhar Journal of Pharmaceutical Sciences, 0(0), 143-157. https://doi.org/10.21608/ajps.2026.504589
Vancouver
Ahmed HEA, Ashraf A. DISCOVERY OF A NOVEL PHENYLAMINE-PURINE CHEMOTYPE AS A POTENTIAL EGFR INHIBITOR USING AN INTEGRATED AI-DRIVEN DRUG DESIGN PIPELINE. Al-Azhar Journal of Pharmaceutical Sciences. 2026;0(0):143-157. doi:10.21608/ajps.2026.504589
BibTeX
@article{Ahmed2026,
author = {Ahmed, Hany E. A. and Ashraf, Abdullah},
title = {DISCOVERY OF A NOVEL PHENYLAMINE-PURINE CHEMOTYPE AS A POTENTIAL EGFR INHIBITOR USING AN INTEGRATED AI-DRIVEN DRUG DESIGN PIPELINE},
journal = {Al-Azhar Journal of Pharmaceutical Sciences},
year = {2026},
volume = {0},
number = {0},
pages = {143--157},
doi = {10.21608/ajps.2026.504589}
}
EUVIMED